Comorbidity of mood disorders and substance use disorders: in concert and co-travelling
Depression and smoking prove a persistent combination: research shows why integrated care is urgently needed
Psychiatric disorders often occur together. This phenomenon - comorbidity - is not only common but also remarkably persistent: people who develop multiple problems at the same time tend to keep them for long periods. Research by psychiatrist Wendela ter Meulen sheds light on why this happens and what the societal consequences are.
More symptoms, more risks
A synthesis of existing studies on the most common combination - depression and anxiety - shows that people who experience both conditions suffer from more severe psychological symptoms and face a higher risk of physical health problems, social limitations, and reduced quality of life. Psychosocial factors, such as childhood trauma, play a significant role in the development of this double burden.
People with depression smoke the most
In a follow-up study, Ter Meulen compared risk factors for smoking among people with and without depression. The differences were striking: people with depression not only smoke far more often, but they also encounter circumstances - such as financial hardship or stressful living conditions - that reinforce smoking behaviour. This makes quitting substantially more difficult.
Disease progression as the silent driver of comorbidity
Ter Meulen also examined the long-term course of mood disorders. Some people recover less well from depression or experience more episodes of bipolar mood instability. This so-called disease progression appears to be the main driver behind the persistent pairing of mood disorders and substance-use problems. In addition, a clinical assessment tool that measures comorbidity seems reasonably able to predict which people with depression later develop bipolar disorder.
Impact and opportunities for healthcare
The findings make clear that comorbidity leads to a stacking of risks and adverse outcomes - psychological, physical, and social. This underscores the need for integrated care, in which conditions are not treated separately but addressed together within a single care pathway. A lesser-known but socially relevant insight is that early in the course of bipolar disorder, a vulnerable period may exist in which substance use is especially destabilising. According to the researchers, education and prevention could yield significant benefits here.
Smokers with depression also deserve special attention: they often succeed in reducing their smoking only after their depressive symptoms improve - sometimes even partially is enough. This calls for treatment approaches that tackle depression and addiction simultaneously, such as combined psychotherapy. Ter Meulen’s work shows that better, integrated care not only helps individual patients but may also reduce health problems, lower dropout from work or education, and ultimately decrease societal costs.
More information on the thesis